HETEROCYCLIC COMPOUNDS AS STING AGONISTS

The disclosure relates to a compound represented by Formula 1, or a pharmaceutically acceptable salt thereof, as a stimulator of interferon genes (STING) agonist, pharmaceutical compositions comprising the same, and related methods of and uses in treatment or prevention of disease. L'invention...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	KIM, Sung Min, PARK, Yun-Hee, KIM, Cheol Eui, HAN, Nara, JUNG, Yeong Hun, SON, Eun Ji, CHUNG, Chul-Woong, KIM, Ji Soo, LEE, Kun Jung, LEE, Eun Hye, LIM, So Yeon, SONG, Ho Young, LEE, Youg Cheol
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The disclosure relates to a compound represented by Formula 1, or a pharmaceutically acceptable salt thereof, as a stimulator of interferon genes (STING) agonist, pharmaceutical compositions comprising the same, and related methods of and uses in treatment or prevention of disease. L'invention concerne un composé représenté par la formule 1, ou un sel pharmaceutiquement acceptable de celui-ci, en tant qu'agoniste de STING (stimulateur de gènes d'interféron), des compositions pharmaceutiques le comprenant, ainsi que des méthodes et des utilisations associées pour le traitement ou la prévention d'une maladie.